Search Articles

View query in Help articles search

Search Results (1 to 2 of 2 Results)

Download search results: CSV END BibTex RIS


Strategies to Improve Health Care Provider Prescription of and Patient Adherence to Guideline-Recommended Cardiovascular Medications for Atherosclerotic Occlusive Disease: Protocol for Two Systematic Reviews and Meta-Analyses of Randomized Controlled Trials

Strategies to Improve Health Care Provider Prescription of and Patient Adherence to Guideline-Recommended Cardiovascular Medications for Atherosclerotic Occlusive Disease: Protocol for Two Systematic Reviews and Meta-Analyses of Randomized Controlled Trials

Studies also report that patient adherence percentages to these medications range from ~70% to 80% for antiplatelets, ~50% to 60% for statins, ~40% to 70% for antihypertensives, and ~20% to 40% for all three guideline-recommended cardiovascular medications [17,18]. Those with PAD are also significantly less likely to be prescribed these medications and adhere to them compared to those with CVD and CAD [19].

Aidan M Kirkham, Dean A Fergusson, Justin Presseau, Daniel I McIsaac, Risa Shorr, Derek J Roberts

JMIR Res Protoc 2025;14:e60326

Associations of Medications With Lower Odds of Typical COVID-19 Symptoms: Cross-Sectional Symptom Surveillance Study

Associations of Medications With Lower Odds of Typical COVID-19 Symptoms: Cross-Sectional Symptom Surveillance Study

Medications listed included cholesterol-lowering medication (eg, simvastatin), nonsteroid anti-inflammatory drugs (NSAIDs, such as ibuprofen and diclofenac), thyroid medication (eg, levothyroxine), omeprazole/pantoprazole, metamizole, antihypertensives, furosemide or hydrochlorothiazide (HCT), cortisone, disease-modifying antirheumatic drugs (DMARDs, eg, methotrexate, biologics, hydroxychloroquine, and antihistamines).

Dietmar Urbach, Friedemann Awiszus, Sven Leiß, Tamsin Venton, Alexander Vincent De Specht, Christian Apfelbacher

JMIR Public Health Surveill 2020;6(4):e22521